Literature DB >> 21235852

Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Giancarlo Maria Liumbruno1, Francesco Bennardello, Angela Lattanzio, Pierluigi Piccoli, Gina Rossetti.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21235852      PMCID: PMC3021395          DOI: 10.2450/2010.0074-10

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  204 in total

Review 1.  Fas, Fas ligand,and transfusion immunomodulation.

Authors:  F Puppo; M Ghio; P Contini; C Mazzei; F Indiveri
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

2.  Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  C A Schiffer; K C Anderson; C L Bennett; S Bernstein; L S Elting; M Goldsmith; M Goldstein; H Hume; J J McCullough; R E McIntyre; B L Powell; J M Rainey; S D Rowley; P Rebulla; M B Troner; A H Wagnon
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

Review 3.  Herbal medicines and perioperative care.

Authors:  M K Ang-Lee; J Moss; C S Yuan
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

4.  In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?

Authors:  M Ghio; P Contini; C Mazzei; A Merlo; G Filaci; M Setti; F Indiveri; F Puppo
Journal:  Transfusion       Date:  2001-08       Impact factor: 3.157

5.  In vitro and in vivo measurements of human RBCs frozen with glycerol and subjected to various storage temperatures before deglycerolization and storage at 4 degrees C for 3 days.

Authors:  C R Valeri; L E Pivacek; G P Cassidy; G Ragno
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

Review 6.  Pharmacologic preservation of the hemostatic system during cardiac surgery.

Authors:  J H Levy
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

7.  Utilization of technologies to reduce allogeneic blood transfusion in the United States.

Authors:  A B Hutchinson; D Fergusson; I D Graham; A Laupacis; J Herrin; C D Hillyer
Journal:  Transfus Med       Date:  2001-04       Impact factor: 2.019

8.  Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss.

Authors:  C R Valeri; G Cassidy; L E Pivacek; G Ragno; W Lieberthal; J P Crowley; S F Khuri; J Loscalzo
Journal:  Transfusion       Date:  2001-08       Impact factor: 3.157

Review 9.  Platelet transfusion trigger in difficult patients.

Authors:  P Rebulla
Journal:  Transfus Clin Biol       Date:  2001-06       Impact factor: 1.406

10.  The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy.

Authors:  T Asaf; H Reuveni; T Yermiahu; A Leiberman; G Gurman; A Porat; P Schlaeffer; S Shifra; J Kapelushnik
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2001-12-01       Impact factor: 1.675

View more
  30 in total

1.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

2.  Preoperative autologous blood donation in lower limb arthroplasty surgery: has the time come for its retirement?

Authors:  Manuel Muñoz; José A García-Erce
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

3.  Low vacuum re-infusion drains after total knee arthroplasty: is there a real benefit?

Authors:  Manuel Muñoz; Andrés Cobos; Arturo Campos
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

4.  Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.

Authors:  Lise J Estcourt; Callum Ingram; Carolyn Doree; Sally Hopewell; Marialena Trivella; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02

5.  Transfusion therapy in the peri-operative period.

Authors:  Giuseppe Aprili; Claudio Velati; Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

6.  Indications and organisational methods for autologous blood transfusion procedures in Italy: results of a national survey.

Authors:  Liviana Catalano; Alessandra Campolongo; Maurizio Caponera; Alessandra Berzuini; Andrea Bontadini; Giuseppe Furlò; Patrizio Pasqualetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

7.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

8.  The Italian Regulatory Guidelines for the implementation of Patient Blood Management.

Authors:  Stefania Vaglio; Sara Gentili; Giuseppe Marano; Simonetta Pupella; Daniela Rafanelli; Gianni Biancofiore; Paola Antonioli; Claudio Velati; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-05-03       Impact factor: 3.443

Review 9.  Red blood cell transfusion policy: a critical literature review.

Authors:  Massimo Franchini; Giuseppe Marano; Carlo Mengoli; Simonetta Pupella; Stefania Vaglio; Manuel Muñoz; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-07       Impact factor: 3.443

10.  Fibrinogen concentrate in surgery.

Authors:  Giuseppe Marano; Carlo Mengoli; Massimo Franchini; Stefania Vaglio; Sara Gentili; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-03-09       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.